Search

everythinglearnresearchcommunity

for

Search:↓

Lower lipin 1β in belly fat is linked to insulin resistance in people with polycystic ovary syndrome.

Lean and obese women with PCOS have similar levels of insulin resistance, indicating it's a core aspect of the condition.

Blocking the ATX-LPA pathway may improve insulin sensitivity and mitochondrial function in obesity.

Girls with PCOS during adolescence have a higher risk of developing type 2 diabetes, and early treatment can help manage this risk.

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.

Teens with PCOS and a mom with PCOS have higher insulin resistance and lower adiponectin levels, which could signal early metabolic problems.

A new gene mutation causes insulin resistance in a girl and her mother.

Women with Polycystic Ovary Syndrome (PCOS) have lower levels of a substance called DIAPH1 in their blood, which is linked to changes in sugar metabolism and insulin resistance.

Women with PCOS have higher 5α-reductase activity, which may be linked to insulin resistance.

PCOS is a complex condition with major health impacts, needing more research for better diagnosis and treatment.

PCOS symptoms change with age; younger women have higher androgen levels and less metabolic issues, while older women face more metabolic challenges despite milder PCOS symptoms.

SHBG may be a useful early indicator and treatment target for PCOS.

The document concludes that managing PCOS involves treating symptoms and reducing long-term metabolic risks, with lifestyle changes being important.

PCOS is diagnosed when at least two of these three features are present: polycystic ovaries, irregular ovulation, and high androgen levels.

Early signs of PCOS in girls, like irregular periods and polycystic ovaries, suggest a need for early diagnosis and intervention to prevent further health issues.

Managing metabolic syndrome needs both lifestyle changes and medical treatments.

New treatments are needed for PCOS that target its genetic, hormonal, and metabolic causes.

Heat Shock Proteins are important in the development of Polycystic Ovarian Syndrome and could be targets for new treatments.

Tissue-derived extracellular vesicles are crucial for cancer diagnosis, prognosis, and treatment.

Exercise improves insulin sensitivity and hormone regulation in PCOS rats.

A low-starch/low-dairy diet may help overweight women with PCOS lose weight and improve metabolism, but more research is needed.

Melatonin may help treat PCOS symptoms in rats.

Taking 5α-reductase inhibitors with prednisolone can worsen its negative effects on metabolism.

A mother's western diet can make her milk toxic, causing inflammation and hair loss in babies.

Natural 5α-reduced glucocorticoids might be anti-inflammatory with fewer side effects than current options.

Electro-acupuncture may help treat PCOS in rats by changing brain DNA methylation.

The document describes various skin conditions, their features, and treatments but lacks detailed study size information.

The document concludes that careful history and physical exams are crucial for accurately diagnosing polycystic ovary syndrome and distinguishing it from other similar conditions.

The document concludes that adenosine receptor agonists have potential for treating various conditions, but only a few are approved due to challenges like side effects and the need for selective activation.

Young girls whose mothers have PCOS may have higher activity of a specific enzyme that could lead to developing PCOS later.